Arkolith/Insider Trading/HRMY/Form 4

Kapadia Sandip

CHIEF FINANCIAL OFFICERHarmony Biosciences Holdings, Inc. (HRMY) · full profile →Form 4 · filed Dec 9, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$791K
Net Open-Market Flow
-$791K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 5, 2025Option exercise(M)20K$29.03$581K20K
Dec 5, 2025Sell(S)20K$39.54$791K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 5, 2025Option exercise(M)20K—$0185K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001677141-25-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML